Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Heron Therapeutics Inc (Symbol: HRTX), where a total volume of 12,128 contracts ...

We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th. Among them, Facebook and Microsoft ranked among the top 3 picks and ...

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than ...

Investors are always looking for stocks that are poised to beat at earnings season and Heron Therapeutics, Inc.HRTX may be one such company. The firm has earnings coming up pretty soon, and events are ...

Heron Therapeutics Inc. Annual stock financials by MarketWatch. View the latest HRTX financial statements, income statements and financial ratios.

HRTX has received approval for its supplemental New Drug Application for Zynrelef, allowing its use in more surgical procedures. The company has partnered with Crosslink Life Sciences to promote ...

HRTX recently launched a fourth drug, Aponvie, with the first full quarter of product sales to come with Q2'23 earnings. An upcoming potential expansion of the Zynrelef label could see the drug used ...

It would take short sellers more than six sessions to buy back their shorted shares Heron Therapeutics Inc (NASDAQ:HRTX) just popped up in a study run by Schaeffer's Senior Quantitative Analyst Rocky ...